Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
Welcome to the latest ITP Australia – The Count Spring 2023 Edition.
Our quarterly newsletter includes information on the latest updates and activities by ITP Australia and in the world of Immune Thrombocytopenia.
Spotlight on the ITP International Alliance – PTI Brasil and Marilia Lia
MEET – CONNECT – SHARE – Join us online during our regular Virtual Patient Meetings.
Danielle and Patricia from ITP Australia had the wonderful experience of attending the UK ITP Support Association’s Patient Convention on Saturday, 13 May 2023.
Spending time taking care of yourself is not selfish. It’s critical to good health.
Welcome to the latest ITP Australia – The Count Winter 2023 Edition.
Our quarterly newsletter includes information on the latest updates and activities by ITP Australia and in the world of Immune Thrombocytopenia.
The current contract arrangements for the supply of imported immunoglobulin products commenced on 1 January 2021. Those arrangements included provisions for some additional products to be added as they became available. The National Blood Authority is now pleased to announce that a new imported intravenous immunoglobulin (IVIg) product, Kiovig 10% (Takeda), will be available to order from Lifeblood from 1 May 2023.
Written by Barbara Louvrencic – ITP Warrior, President of AIPIT Italy
Shared from UK ITP Support Association The Platelet published in November 2022.
The title could already be a story “ITP- in viaggio con Werlhof” in English “ITP- a journey with Werlhof” is an awareness campaign promoted by Sobi Italia with Aipit aps Onlus support.
From January 1, access to Thrombopoietin Receptor Agonists (TPORAs) became much easier for patients living with Immune Thrombocytopenia (ITP).
ITP Australia has worked to illuminate various locations across the country for the last couple of years to help raise awareness for Immune Thrombocytopenia.